HAVCR1 and pancreatic adenocarcinoma: The ROC curves revealed that the AUCs of HAVCR1 for predicting the 5-years survival of Liver hepatocellular carcinoma and Pancreatic adenocarcinoma patients were 0.738 and 0.619, respectively (Figures 6A,B).